BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• MGC Pharmaceuticals Set To Sponsor And Speak At Cannatech UK, The First Ever Medical Cannabis Conference In London

  September 25, 2017

   · 

  2 min read
• Business

  EpiVax Launches Precision Cancer Immunotherapy Venture, EpiVax Oncology

  September 25, 2017

   · 

  3 min read
• Business

  Sema4 Partners With PWNHealth To Enable Genetic Testing For Consumers Nationwide

  September 25, 2017

   · 

  2 min read
• Policy

  Amsel Medical Announces Clearance Of A 510(K) Pre-Marketing Notification By The U.S. FDA For The Low-Profile Amsel Occluder Device

  September 25, 2017

   · 

  3 min read
• Policy

  LabCorp Objects To Proposed PAMA 2018 Medicare Payment Rates For Clinical Laboratory Tests; Calls For Delay In Implementation To Avoid Significant Harm To Medicare Beneficiaries

  September 25, 2017

   · 

  3 min read
• Drug Development

  Exelixis Provides Update On Collaborator Daiichi Sankyo, Inc.’s Phase III Clinical Progress With Esaxerenone (CS-3150), Including Positive Top-Line Results And Additional Pivotal Study

  September 25, 2017

   · 

  11 min read
• FDA

  FDA Approves Merck & Co.’s KEYTRUDA (Pembrolizumab) For Previously Treated Patients With Recurrent Locally Advanced Or Metastatic Gastric Or Gastroesophageal Junction Cancer Whose Tumors Express PD-L1 (CPS Greater Than Or Equal To 1)

  September 25, 2017

   · 

  1 min read
• Cannabics Pharma Files National Phase Applications For Its System And Method For High Throughput Screening Of Cancer Cells

  September 25, 2017

   · 

  3 min read
• Mettler-Toledo Release: New First-Defect-Stop Guide Puts Lean Management Principles To Work In The Laboratory

  September 25, 2017

   · 

  3 min read
• Drug Development

  AMO Pharma Reports Update On Positive Interim Analysis For The First Cohort Of Phase IIa Congenital Myotonic Dystrophy Study

  September 25, 2017

   · 

  4 min read